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Introduction
Systemic lupus erythematosus (SLE) is a multisystem
disease that is rarely seen in childhood. Diagnosing this
disease in childhood is a challenge since it has a variable
presentation. The progress of the disease also varies
during childhood.
Objectives
We aimed to review the clinical and laboratory findings
and disease progress of the patients who were diagnosed
as juvenile onset SLE in our pediatric rheumatology
department during the last 10 years.
Methods
Ninety subjects who were diagnosed as juvenile onset
SLE according to the 1982 ACR SLE classification
criteria during the last 10 years were included in the
study. All of the patients had a follow-up period of at
least 1 year. The clinical findings, progress of the disease
and response to treatment were all recorded retrospec-
tively from patient files.
Results
Of the 90 subjects, 79 were female and 11 were male.
Mean age at the onset of disease was 10.2 ± 2.9 years
(range 3.1-16 years), and mean age at the time of diagno-
sis was 11.6 ± 3 years (range 3,8-16 years). Twenty two
(24.4%) of the subjects had been followed up initially
with a different diagnosis. Eighty (88.8%) of the patients
had malar rash, 32 (35.6%) had oral ulcer, 55 (61.1%) had
a non-deforming polyarthritis, 12 (13.3%) had serositis (7
pericarditis and 5 pleuritis). None of the patients
developed avascular necrosis. Thirty eight (42.2%) of the
patients had renal involvement. Of the patients with renal
involvement, 5 progressed to end stage renal disease
requiring hemodialysis. These 5 patients were those who
were noncompliant with their periodic controls. Seven-
teen (18.8%) patients had neurologic involvement. None
of the patients developed any irreversible neurologic
sequela. At the onset of diagnosis, 88 (97.7%) of the
patients had ANA positivity. Twelve (13.3%) of the
patients had a family history of autoimmune disease. Ten
patients developed secondary antiphospholipid syndrome
during follow up. All of the patients were given corticos-
teroid treatment at varying doses. Patients with renal
involvement were given cyclophosphamide therapy.
Azathioprine and mycophenolate mofetil were used in 62
and 19 patients, respectively. The mean durations of fol-
low up were 62 months (range 12-120 months). Three
patients died during the follow up period (due to sepsis,
antiphospholipid syndrome, eosaphageal varices hemor-
rhage). Patients who were over 20 years of age were
transferred to adult rheumatology department.
Conclusion
Juvenile onset SLE is a disease that can present with dif-
ferent and varying findings. Complications can be les-
sened and long term sequela can be prevented with
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